PRTT (Protect Pharmaceutical) EBIT: $-0.00 Mil (TTM As of Jun. 2018)


What is Protect Pharmaceutical EBIT?

Protect Pharmaceutical PRTT EBIT is $-0.00 Mil as of Jun. 2018.

Protect Pharmaceutical's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2018 was $-0.00 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2018 was $-0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Protect Pharmaceutical's annualized ROC % for the quarter that ended in Jun. 2018 was %. Protect Pharmaceutical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2018 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Protect Pharmaceutical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2018 was -0.03%.

Protect Pharmaceutical  (OTCPK:PRTT) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Protect Pharmaceutical's annualized ROC % for the quarter that ended in Jun. 2018 is calculated as:

ROC % (Q: Jun. 2018 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2018 ) + Invested Capital (Q: Jun. 2018 ))/ count )
=-0.004 * ( 1 - 0% )/( (0 + 0)/ 1 )
=-0.004/0
= %

where

Invested Capital(Q: Mar. 2018 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0 - 0.046 - ( 0 - max(0, 0.046 - 0+0))
=0

Invested Capital(Q: Jun. 2018 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.02 - 0.051 - ( 0.02 - max(0, 0.051 - 0.02+0.02))
=0

Note: The Operating Income data used here is four times the quarterly (Jun. 2018) data.

2. Joel Greenblatt's definition of Return on Capital:

Protect Pharmaceutical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2018 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2018 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2018  Q: Jun. 2018
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.004/( ( (0 + max(-0.046, 0)) + (0 + max(-0.051, 0)) )/ 1 )
=-0.004/( ( 0 + 0 )/ 1 )
=-0.004/0
= %

where Working Capital is:

Working Capital(Q: Mar. 2018 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.046 + 0 + 0)
=-0.046

Working Capital(Q: Jun. 2018 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.051 + 0 + 0)
=-0.051

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2018) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Protect Pharmaceutical's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2018 )
=-0.001/3.447
=-0.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Protect Pharmaceutical EBIT Related Terms

Protect Pharmaceutical EBIT Historical Data

* Premium members only.

The historical data trend for Protect Pharmaceutical's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Protect Pharmaceutical EBIT Chart

Protect Pharmaceutical Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
EBIT
Get a 7-Day Free Trial Premium Member Only -0.02 -0.03 -0.03 -0.04 -0.12

Protect Pharmaceutical Quarterly Data
Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 0.00 0.00 0.00 -0.00

PRTT vs PVEG, FCIC, USAQ: EBIT Comparison

For the Integrated Freight & Logistics subindustry, Protect Pharmaceutical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Protect Pharmaceutical EV-to-EBIT vs Transportation Industry

For the Transportation industry and Industrials sector, Protect Pharmaceutical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Protect Pharmaceutical's EV-to-EBIT falls into.


Protect Pharmaceutical EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-0.00 Mil mean?
Protect Pharmaceutical (PRTT) has a EBIT of $-0.00 Mil as of Jun. 2018. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Protect Pharmaceutical.
Is Protect Pharmaceutical's EBIT too high?
Protect Pharmaceutical's current EBIT is $-0.00 Mil.
How does Protect Pharmaceutical's EBIT compare to PVEG and FCIC?
Protect Pharmaceutical's EBIT of $-0.00 Mil can be compared against companies in the Transportation industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Transportation company?
A good EBIT depends on the Transportation industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Protect Pharmaceutical. Protect Pharmaceutical's current EBIT is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Protect Pharmaceutical stock overvalued right now?
Protect Pharmaceutical (PRTT) has a current EBIT of $-0.00 Mil. The current EBIT is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Protect Pharmaceutical (PRTT), the current EBIT is $-0.00 Mil as of Jun. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Protect Pharmaceutical Business Description

Address 30 N Gould St, Suite R, Sheridan, WY, USA, 82801
Protect Pharmaceutical Corp is engaged in Textiles and Software as a Service.